+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Metabolomics Market by Product & Service, Indication, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674898
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Metabolomics Market grew from USD 3.74 billion in 2023 to USD 4.28 billion in 2024. It is expected to continue growing at a CAGR of 15.06%, reaching USD 9.99 billion by 2030.

Metabolomics, the comprehensive study of small molecules and metabolic pathways within biological systems, has gained attention for its applications in precision medicine, personalized nutrition, and disease diagnosis. The necessity of metabolomics stems from its role in understanding metabolic alterations related to diseases, drug responses, and environmental influences. Its end-use spans pharmaceuticals, biotech companies, research institutes, food and nutrition industries, and environmental agencies, driving demand for tools and technologies in metabolite profiling, data analysis, and biomarker discovery. Significant market growth factors include advances in analytical technologies like mass spectrometry and nuclear magnetic resonance, the rising prevalence of chronic diseases, and increased funding for research. Digitization and automation in laboratory processes also contribute to scaling operations and enhancing data accuracy. Notably, Asia-Pacific is emerging as a lucrative market due to investments in healthcare infrastructure and research. However, challenges such as high costs of instruments, the complexity of data interpretation, and the need for standardized procedures may hinder growth. Intellectual property concerns and data privacy issues also pose risks. To seize latest opportunities, companies can focus on collaborative research initiatives and developing cost-effective, user-friendly platforms for data collection and analysis. Moreover, exploring the integration of AI and machine learning for data analysis offers substantial potential for innovation. Personalized healthcare and systems biology are ripe fields for metabolomics advances and new solutions. While competition is intensifying, the market's fragmented nature presents opportunities for strategic partnerships and niche specialization. Innovations in disease diagnostics, nutritional metabolomics, and environmental metabolomics can yield significant business growth. By investing in robust training and support services, firms can ease adoption hurdles, leading to broader acceptance and utilization in various industries. While metabolomics holds promise, its growth will rely heavily on overcoming technological and operational challenges through strategic, targeted innovation.

Understanding Market Dynamics in the Metabolomics Market

The Metabolomics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of cancer cases and need for advanced therapies
    • Ongoing adoption of personalized medicines
    • Favorable governmental initiatives associated with metabolomics research
  • Market Restraints
    • Concern regarding the complex data monitoring and data processing
  • Market Opportunities
    • Emergence of novel technologies along with market players for metabolomics
    • Rise of single-cell metabolomics
  • Market Challenges
    • Scarcity of skilled professionals in the healthcare sectors worldwide

Exploring Porter’s Five Forces for the Metabolomics Market

Porter’s Five Forces framework further strengthens the insights of the Metabolomics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Metabolomics Market

External macro-environmental factors deeply influence the performance of the Metabolomics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Metabolomics Market

The Metabolomics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Metabolomics Market

The Metabolomics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Metabolomics Market

The Metabolomics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metabolomics Market, highlighting leading vendors and their innovative profiles. These include Afekta Technologies Ltd., Bio-Rad Laboratories, Inc., Biocrates Life Science AG, Bruker Corporation, Danaher Corporation, General Electric Company, Hitachi High-Tech Corporation, Human Metabolome Technologies America Inc., Japan Spectroscopic Company, Kore Technology Limited, LECO Corporation, Merck KGaA, SCION Instruments UK Ltd, Shimadzu Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Metabolomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product & Service
    • Bioinformatics Tools & Services
      • Bioinformatics Services
      • Bioinformatics Tools & Databases
    • Metabolomics Instruments
      • Detection Tools
        • Mass Spectrometry
        • Nuclear Magnetic Resonance Spectroscopy
        • Surface-Based Mass Analysis
      • Separation Tools
        • Capillary Electrophoresis
        • Gas Chromatography
        • High-performance Liquid Chromatography
        • Ultra-performance Liquid Chromatography
  • Indication
    • Cancer
    • Cardiovascular Disorders
    • Inborn Errors of Metabolism
    • Metabolic Disorders
    • Neurological Disorders
  • Application
    • Biomarker discovery
    • Drug discovery
    • Functional Genomics
    • Nutrigenomics
    • Personalized medicine
    • Toxicology testing
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer cases and need for advanced therapies
5.1.1.2. Ongoing adoption of personalized medicines
5.1.1.3. Favorable governmental initiatives associated with metabolomics research
5.1.2. Restraints
5.1.2.1. Concern regarding the complex data monitoring and data processing
5.1.3. Opportunities
5.1.3.1. Emergence of novel technologies along with market players for metabolomics
5.1.3.2. Rise of single-cell metabolomics
5.1.4. Challenges
5.1.4.1. Scarcity of skilled professionals in the healthcare sectors worldwide
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Metabolomics Market, by Product & Service
6.1. Introduction
6.2. Bioinformatics Tools & Services
6.2.1. Bioinformatics Services
6.2.2. Bioinformatics Tools & Databases
6.3. Metabolomics Instruments
6.3.1. Detection Tools
6.3.1.1. Mass Spectrometry
6.3.1.2. Nuclear Magnetic Resonance Spectroscopy
6.3.1.3. Surface-Based Mass Analysis
6.3.2. Separation Tools
6.3.2.1. Capillary Electrophoresis
6.3.2.2. Gas Chromatography
6.3.2.3. High-performance Liquid Chromatography
6.3.2.4. Ultra-performance Liquid Chromatography
7. Metabolomics Market, by Indication
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disorders
7.4. Inborn Errors of Metabolism
7.5. Metabolic Disorders
7.6. Neurological Disorders
8. Metabolomics Market, by Application
8.1. Introduction
8.2. Biomarker discovery
8.3. Drug discovery
8.4. Functional Genomics
8.5. Nutrigenomics
8.6. Personalized medicine
8.7. Toxicology testing
9. Metabolomics Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Metabolomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Metabolomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Metabolomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. METABOLOMICS MARKET RESEARCH PROCESS
FIGURE 2. METABOLOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. METABOLOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. METABOLOMICS MARKET DYNAMICS
TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 68. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 69. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 71. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 72. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. CHINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 110. CHINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 111. CHINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 112. CHINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 113. CHINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 114. CHINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. CHINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. CHINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. INDIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 118. INDIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 119. INDIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. INDIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 121. INDIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 122. INDIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. INDIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. INDIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. JAPAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 134. JAPAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 135. JAPAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 137. JAPAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 138. JAPAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. JAPAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. JAPAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. THAILAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 182. THAILAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 183. THAILAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 184. THAILAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 185. THAILAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 186. THAILAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. THAILAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. THAILAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 206. DENMARK METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. DENMARK METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. DENMARK METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. EGYPT METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 216. EGYPT METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EGYPT METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 227. FINLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 228. FINLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. FRANCE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. GERMANY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 240. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 242. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 243. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. GERMANY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. ITALY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 255. ITALY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 256. ITALY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. ITALY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 258. ITALY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 259. ITALY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. ITALY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ITALY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 280. NORWAY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 282. NORWAY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 283. NORWAY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. NORWAY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. NORWAY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. POLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 287. POLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 288. POLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 289. POLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 290. POLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 291. POLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. POLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. QATAR METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 295. QATAR METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 296. QATAR METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. QATAR METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 298. QATAR METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 299. QATAR METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. QATAR METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. QATAR METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SPAIN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 328. SPAIN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 329. SPAIN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 330. SPAIN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 331. SPAIN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 332. SPAIN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. SPAIN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. TURKEY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 351. TURKEY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 352. TURKEY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 354. TURKEY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 355. TURKEY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 356. TURKEY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
T

Companies Mentioned

The leading players in the Metabolomics Market, which are profiled in this report, include:
  • Afekta Technologies Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Danaher Corporation
  • General Electric Company
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies America Inc.
  • Japan Spectroscopic Company
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • SCION Instruments UK Ltd
  • Shimadzu Corporation
  • Waters Corporation

Methodology

Loading
LOADING...

Table Information